Post-inflammatory pigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy male or female subjects aged 20–45 years; 2.Have completed mesotherapy (skin booster) treatment; 3.Skin condition on the left and right sides of the face is essentially symmetrical; 4.Agree not to use other skincare products, medications, or undergo other aesthetic procedures that may affect the study outcomes during the trial period; 5.Able to comply with the trial requirements; 6.Provide informed consent and sign the written informed consent form;
Exclusion criteria
Exclusion criteria: 1.History of allergy to hyaluronic acid; 2.Currently suffering from skin diseases or severe allergies, or with a history of treatments that may affect skin healing; 3.Having skin cancer or suspected skin cancer; 4.Received non-absorbable filler injections, laser therapy, or facial implants within the past year; 5.Suffering from severe systemic diseases, such as heart disease or poorly controlled diabetes; 6.Women who are pregnant, breastfeeding, or planning to become pregnant during the treatment period; 7.History of keloid formation or abnormal wound healing; 8.Skin hypersensitivity; 9.Unable to avoid prolonged and intense sun exposure in the near future (e.g., long-term outdoor workers); 10.Suffering from psychiatric disorders or other conditions that may affect treatment compliance; 11.Deemed unsuitable for participation in the trial based on clinical evaluation;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transepidermal Water Loss;Skin redness degree (a value); | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment; | — |
Countries
China
Contacts
West China Hospital of Sichuan University